Family Medicine Doctors in Kansas Medicare Details, Address, Contact

1888 Family Medicine doctors found. Showing 1 - 20

Michael Gary Ziegler, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 511 Ne 10th St, Abilene, KS 67410 Phone: 785-263-4131    Fax: 785-263-1634

Mark Douglas Sheern, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1111 N Brady St, Abilene, KS 67410 Phone: 785-263-4131    Fax: 785-263-1634

Kimberly Hinman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 511 Ne 10th St, Abilene, KS 67410 Phone: 785-263-4131    Fax: 785-263-1634

Brian L Holmes, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 511 Ne 10th St, Abilene, KS 67410 Phone: 785-263-4131

Allison Dawn Thompson, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 511 Ne 10th St, Abilene, KS 67410 Phone: 785-263-4131    Fax: 785-263-2774

J. Dennis Biggs, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1405 N Cedar St, Abilene, KS 67410 Phone: 785-263-7190    Fax: 785-263-7390

J Steven Schwarting, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1405 N Cedar St, Abilene, KS 67410 Phone: 785-263-7190    Fax: 785-263-7390

Mrs. Ashley C Barta, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 511 Ne 10th St, Abilene, KS 67410 Phone: 785-263-6660    Fax: 785-263-6633

William L Short, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 N Brady St, Abilene, KS 67410 Phone: 785-263-4131    Fax: 785-263-1634

Derek Surdez, Family Medicine Medicare: Medicare Enrolled Practice Location: 105 S Andover Rd, Andover, KS 67002 Phone: 316-330-2773

Matthew G Meschke, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-733-1331    Fax: 316-733-4916

Dr. James Marshall Hartley, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 524 N Andover Rd, Andover, KS 67002 Phone: 316-733-3002    Fax: 316-733-1240

Micah Hall, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 S Andover Rd Ste D, Andover, KS 67002 Phone: 316-733-5120    Fax: 316-733-1280

Michael Wilson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 612 N Andover Rd, Andover, KS 67002 Phone: 316-733-6618    Fax: 316-733-5299

Candi S Nigh, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 524 N Andover Rd, Andover, KS 67002 Phone: 316-733-0716    Fax: 316-733-6997

Stephen F Lemons, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 308 E Central Ave, Andover, KS 67002 Phone: 316-733-1331    Fax: 316-733-4916

Tara Katz, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 612 N Andover Rd, Andover, KS 67002 Phone: 316-733-6618    Fax: 316-733-5299

Dr. Lindsay Marie Landers, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 S Andover Rd, Suite D, Andover, KS 67002 Phone: 316-733-5120    Fax: 316-733-1280

Charles R Green, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 612 N Andover Rd, Andover, KS 67002 Phone: 316-733-6618    Fax: 316-733-5299

Ryan Woodruff, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 105 S Andover Rd Ste D, Andover, KS 67002 Phone: 316-925-7871

News Archive

Researchers identify potential therapeutic target in treatment of certain AML

Acute myeloid leukemia (AML) is a group of heterogeneous diseases with considerable diversity in terms of genetic abnormalities. Mutations of CEBPA, a tumour suppressor, are found in about 10 per cent of human AML patients. In two separate studies on CEBPA mutations in AML subtypes, researchers successfully identified and validated a gene known as Sox4 as a potential therapeutic target and a class of anti-cancer drugs, histone deacetylase (HDAC) inhibitors, as potential candidates in the treatment of certain AML.

New technology to diagnose fatal disease in preemies granted FDA's Breakthrough Device Designation

A technology to diagnose a potentially fatal disease in premature infants invented by Sunyoung Kim, PhD, Professor of Biochemistry & Molecular Biology at LSU Health New Orleans School of Medicine, has been granted a Breakthrough Device Designation by the Food and Drug Administration.

COVID ‐19 stay‐at‐home orders influence health behaviors of patients with obesity

Shelter-in-place orders to reduce the spread of COVID-19 put unusual strains on people with obesity, making it more difficult for them to eat properly and manage their weight, according to a UT Southwestern study.

Neogenix awarded $488,958.50 grant under QTDP program

Neogenix Oncology, Inc. announced today that the company has been awarded two grants totaling $488,958.50, under the Qualifying Therapeutic Discovery Project Program. The two successful applications were for the company's h16C3 therapeutic antibody development program and the diagnostic biomarker development program for both their h16C3 and NPC-1C antibodies.

Hospital-wide clinical improvement initiative for patients at risk for DASH reduces readmission rates

Brigham and Women's Hospital finds that developing and implementing an interdisciplinary care improvement initiative improves outcomes.

Read more Medical News

› Verified 5 days ago

• 1(current)
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• »